Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNTHc in mice.
Mol Med Rep
; 15(4): 2369-2373, 2017 Apr.
Article
en En
| MEDLINE
| ID: mdl-28259925
In developing countries, trauma patients and neonates are vulnerable to Staphylococcus aureus (S. aureus) and Clostridium tetani infections. It has been suggested that a combined vaccine against the two infections may be a reliable and costeffective strategy. Previous studies have indicated that the S. aureus surface protein A (SasA) and the C fragment of tetanus neurotoxin (TeNTHc) may be suitable candidates for a vaccine against S. aureus and tetanus infections, respectively. In the present study, mice were immunized with a combined vaccine containing SasA and TeNTHc, which induced a robust immune response to both antigens, and mutual interference between SasA and TeNTHc was not observed. In the S.aureus challenge model, the combined vaccine fully protected BALB/c mice against lethal intraperitoneal challenges with 3x109 colonyforming units of a methicillinresistant S. aureus USA300 strain. In the TeNT challenge model, the combined vaccine conferred complete protection against a lethal dose of (2x103) xLD50 tetanus toxin. These results implied that SasA and TeNTHc promising components for a combined vaccine against S. aureus and tetanus infections.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones Estafilocócicas
/
Staphylococcus aureus
/
Tétanos
/
Vacunas Estafilocócicas
/
Toxoide Tetánico
/
Clostridium tetani
Límite:
Animals
Idioma:
En
Revista:
Mol Med Rep
Año:
2017
Tipo del documento:
Article
Pais de publicación:
Grecia